Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Linda Stertman, Anna-Karin E. Palm, Behdad Zarnegar, Berit Carow, Carolina Lunderius Andersson, Sofia E. Magnusson, Cecilia Carnrot, Vivek Shinde, Gale Smith, Gregory Glenn, Louis Fries & Karin Lövgren Bengtsson. (2023) The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Asim Biswas, Rahul Shubhra Mandal, Suparna Chakraborty & George Maiti. (2022) Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population. International Reviews of Immunology 41:4, pages 448-463.
Read now
Read now
Articles from other publishers (28)
Adrián Plata & Alberto Fernández‐Tejada. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics
73
110
.
Cecilia Carnrot, Berit Carow, Anna-Karin E. Palm, Eray Akpinar, Per-Henrik Helgesson, Ingrid Lekberg Osterman, Emelie Bringeland, Bryant Foreman, Nita Patel, Johan Bankefors, Louis Fries & Linda Stertman. (2023) Biodistribution of the saponin-based adjuvant Matrix-M™ following intramuscular injection in mice. Frontiers in Drug Delivery 3.
Crossref
Crossref
Angelina Kovalenko, Ekaterina Ryabchevskaya, Ekaterina Evtushenko, Nikolai Nikitin & Olga Karpova. (2023) Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress. International Journal of Molecular Sciences 24:2, pages 1701.
Crossref
Crossref
Agustín Valenzuela-Fernández, Romina Cabrera-Rodriguez, Laura Ciuffreda, Silvia Perez-Yanes, Judith Estevez-Herrera, Rafaela González-Montelongo, Julia Alcoba-Florez, Rodrigo Trujillo-González, Diego García-Martínez de Artola, Helena Gil-Campesino, Oscar Díez-Gil, José M. Lorenzo-Salazar, Carlos Flores & Jonay Garcia-Luis. (2022) Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Alexander Domnich, Andrea Orsi, Carlo-Simone Trombetta, Giulia Guarona, Donatella Panatto & Giancarlo Icardi. (2022) COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy. Pharmaceuticals 15:3, pages 322.
Crossref
Crossref
Vivek Shinde, Iksung Cho, Joyce S Plested, Sapeckshita Agrawal, Jamie Fiske, Rongman Cai, Haixia Zhou, Xuan Pham, Mingzhu Zhu, Shane Cloney-Clark, Nan Wang, Bin Zhou, Maggie Lewis, Patty Price-Abbott, Nita Patel, Michael J Massare, Gale Smith, Cheryl Keech, Louis Fries & Gregory M Glenn. (2022) Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial. The Lancet Infectious Diseases 22:1, pages 73-84.
Crossref
Crossref
Susheel K. Singh, Jordan Plieskatt, Bishwanath K. Chourasia, Vandana Singh, Karin Lövgren Bengtsson, Jenny M. Reimer, Renate C. van Daalen, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Matthijs M. Jore & Michael Theisen. (2021) Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine. npj Vaccines 6:1.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Navid D. Djadid & Akram A. Mehrizi. (2021) A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development. International Journal for Parasitology 51:9, pages 699-717.
Crossref
Crossref
Katharine A. Collins, Florian Brod, Rebecca Snaith, Marta Ulaszewska, Rhea J. Longley, Ahmed M. Salman, Sarah C. Gilbert, Alexandra J. Spencer, David Franco, W. Ripley Ballou & Adrian V. S. Hill. (2021) Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice. Scientific Reports 11:1.
Crossref
Crossref
Mehreen S Datoo, Magloire H Natama, Athanase Somé, Ousmane Traoré, Toussaint Rouamba, Duncan Bellamy, Prisca Yameogo, Daniel Valia, Moubarak Tegneri, Florence Ouedraogo, Rachidatou Soma, Seydou Sawadogo, Faizatou Sorgho, Karim Derra, Eli Rouamba, Benedict Orindi, Fernando Ramos Lopez, Amy Flaxman, Federica Cappuccini, Reshma Kailath, Sean Elias, Ekta Mukhopadhyay, Andres Noe, Matthew Cairns, Alison Lawrie, Rachel Roberts, Innocent Valéa, Hermann Sorgho, Nicola Williams, Gregory Glenn, Louis Fries, Jenny Reimer, Katie J Ewer, Umesh Shaligram, Adrian V S Hill & Halidou Tinto. (2021) Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. The Lancet 397:10287, pages 1809-1818.
Crossref
Crossref
Cole J. Batty, Mark T. Heise, Eric M. Bachelder & Kristy M. Ainslie. (2021) Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection. Advanced Drug Delivery Reviews 169, pages 168-189.
Crossref
Crossref
Susheel K. Singh, Jordan Plieskatt, Bishwanath K. Chourasia, Amanda Fabra-García, Asier Garcia-Senosiain, Vandana Singh, Karin Lövgren Bengtsson, Jenny M. Reimer, Robert Sauerwein, Matthijs M. Jore & Michael Theisen. (2021) A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine. Frontiers in Immunology 11.
Crossref
Crossref
Mariusz Skwarczynski, Saranya Chandrudu, Berta Rigau-Planella, Md. Tanjir Islam, Yee S. Cheong, Genan Liu, Xiumin Wang, Istvan Toth & Waleed M. Hussein. (2020) Progress in the Development of Subunit Vaccines against Malaria. Vaccines 8:3, pages 373.
Crossref
Crossref
Erwan Atcheson, Karolis Bauza, Ahmed M. Salman, Eduardo Alves, Joshua Blight, Martha Eva Viveros-Sandoval, Chris J. Janse, Shahid M. Khan, Adrian V. S. Hill & Arturo Reyes-Sandoval. (2018) Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors. Infection and Immunity 86:9.
Crossref
Crossref
Gabriel Ozorowski, Albert Cupo, Michael Golabek, Michelle LoPiccolo, Thomas A. Ketas, Matt Cavallary, Christopher A. Cottrell, P. J. Klasse, Andrew B. Ward & John P. Moore. (2018)
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers
In Vitro
. Journal of Virology 92:13.
Crossref
Crossref
Bernt Hjertner, Theresa Bengtsson, Bror Morein, Staffan Paulie & Caroline Fossum. (2018) A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine. Vaccine 36:23, pages 3340-3344.
Crossref
Crossref
Sofia E. Magnusson, Arwen F. Altenburg, Karin Lövgren Bengtsson, Fons Bosman, Rory D. de Vries, Guus F. Rimmelzwaan & Linda Stertman. (2018) Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice. Immunologic Research 66:2, pages 224-233.
Crossref
Crossref
Navin Venkatraman, Nicholas Anagnostou, Carly Bliss, Georgina Bowyer, Danny Wright, Karin Lövgren-Bengtsson, Rachel Roberts, Ian Poulton, Alison Lawrie, Katie Ewer & Adrian V. S. Hill. (2017) Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™. Vaccine 35:45, pages 6208-6217.
Crossref
Crossref
Ahmed M. Salman, Eduardo Montoya-Díaz, Heather West, Amar Lall, Erwan Atcheson, Cesar Lopez-Camacho, Jai Ramesar, Karolis Bauza, Katharine A. Collins, Florian Brod, Fernando Reis, Leontios Pappas, Lilia González-Cerón, Chris J. Janse, Adrian V. S. Hill, Shahid M. Khan & Arturo Reyes-Sandoval. (2017) Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models. Scientific Reports 7:1.
Crossref
Crossref
Eduardo Alves, Ahmed M. Salman, Fabiana Leoratti, Cesar Lopez-Camacho, Martha Eva Viveros-Sandoval, Amar Lall, Aadil El-Turabi, Martin F. Bachmann, Adrian V. S. Hill, Chris J. Janse, Shahid M. Khan & Arturo Reyes-Sandoval. (2017) Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine. Clinical and Vaccine Immunology 24:4.
Crossref
Crossref
David J. Gasper, Brandon Neldner, Erin H. Plisch, Hani Rustom, Emily Carrow, Hirotaka Imai, Yoshihiro Kawaoka & M. Suresh. (2016) Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines. PLOS Pathogens 12:12, pages e1006064.
Crossref
Crossref
Emilia Bigaeva, Eva van Doorn, Heng Liu & Eelko Hak. (2016) Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability. PLOS ONE 11:5, pages e0154757.
Crossref
Crossref
Karin Lövgren Bengtsson, Haifeng Song, Linda Stertman, Ye Liu, David C. Flyer, Michael J. Massare, Ren-Huan Xu, Bin Zhou, Hanxin Lu, Steve A. Kwilas, Timothy J. Hahn, Eloi Kpamegan, Jay Hooper, Ricardo CarrionJr.Jr., Gregory Glenn & Gale Smith. (2016) Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine 34:16, pages 1927-1935.
Crossref
Crossref
Robyn Marty-Roix, Gregory I. Vladimer, Kimberly Pouliot, Dan Weng, Rachel Buglione-Corbett, Kim West, John D. MacMicking, Jonathan D. Chee, Shixia Wang, Shan Lu & Egil Lien. (2016) Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants. Journal of Biological Chemistry 291:3, pages 1123-1136.
Crossref
Crossref
Freek Cox, Eirikur Saeland, Matthijs Baart, Martin Koldijk, Jeroen Tolboom, Liesbeth Dekking, Wouter Koudstaal, Karin Lövgren Bengtsson, Jaap Goudsmit & Katarina Radošević. (2015) Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine. Virology Journal 12:1.
Crossref
Crossref
Zoltan Beck, Gary R. Matyas, Rashmi Jalah, Mangala Rao, Victoria R. Polonis & Carl R. Alving. (2015) Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21. Vaccine 33:42, pages 5578-5587.
Crossref
Crossref
Babs E. Verstrepen, Herman Oostermeijer, Zahra Fagrouch, Melanie van Heteren, Henk Niphuis, Tom Haaksma, Ivanela Kondova, Willy M. Bogers, Marina de Filette, Niek Sanders, Linda Stertman, Sofia Magnusson, Orsolya Lőrincz, Julianna Lisziewicz, Luisa Barzon, Giorgio Palù, Michael S. Diamond, Stefan Chabierski, Sebastian Ulbert & Ernst J. Verschoor. (2014) Vaccine-Induced Protection of Rhesus Macaques against Plasma Viremia after Intradermal Infection with a European Lineage 1 Strain of West Nile Virus. PLoS ONE 9:11, pages e112568.
Crossref
Crossref
Anthony R. Fooks, Penelope Koraka, Rik L. de Swart, Charles E. Rupprecht & Albert D.M.E. Osterhaus. (2014) Development of a multivalent paediatric human vaccine for rabies virus in combination with Measles–Mumps–Rubella (MMR). Vaccine 32:18, pages 2020-2021.
Crossref
Crossref